PREDICTORS PF REMISSION IN THE TREATMENT OF DEPRESSION IN THE MIDDLE EAST: REAL-WORLD EVIDENCE FROM A 6-MONTH PROSPECTIVE OBSERVATIONAL STUDY

被引：0
|
作者：
Novick, D. [1 ]
Hong, Jihyung J. [1 ]
Montgomery, W. [2 ]
Duenas, H. [3 ]
Elfatarany, G. [4 ]
Haro, J. M. [5 ]
机构：
[1] Eli Lilly Holdings Ltd, Windlesham, Surrey, England
[2] Eli Lilly Australia, Sydney, NSW, Australia
[3] Eli Lilly Mexico, Mexico City, DF, Mexico
[4] Eli Lilly & Co, Riyadh, Saudi Arabia
[5] Univ Barcelona, Parc Sanitari St Joan de Deu, CIBERSAM, Barcelona, Spain
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1240
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PMH7
引用
收藏
页码：A454 / A454
页数：1
相关论文
共 50 条
  • [1] Predictors of remission in the treatment of major depressive disorder: real-world evidence from a 6-month prospective observational study
    Novick, Diego
    Hong, Jihyung
    Montgomery, William
    Duenas, Hector
    Gado, Magdy
    Haro, Josep Maria
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2015, 11 : 197 - 205
  • [2] Real-world effectiveness and safety of Guselkumab for the treatment of psoriasis: a 6-month prospective study in a series of psoriatic patients
    Malara, G.
    Trifiro, C.
    Bartolotta, A.
    Giofre, C.
    D'Arrigo, G.
    Testa, A.
    De Lorenzo, A.
    Tripepi, G.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (01) : 406 - 412
  • [3] Real-World Effectiveness of Upadacitinib in Patients with Moderate/ Severe Rheumatoid Arthritis: 6-Month Data from the Observational UPHOLD Study
    Ostor, Andrew
    Feist, Eugen
    Sidiropoulos, Prodromos
    Avouac, Jerome
    Rebella, Martin
    Namas, Rajaie
    Frediani, Bruno
    Hsieh, Song-Chou
    Gao, Tianming
    Khan, Nasser
    Strengholt, Sander
    Lagunes-Galindo, Ivan
    Attar, Susan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 821 - 824
  • [4] THE REAL-WORLD OBSERVATIONAL PROSPECTIVE STUDY OF HEALTH OUTCOMES WITH DULAGLUTIDE & LIRAGLUTIDE IN TYPE 2 DIABETES PATIENTS (TROPHIES): 6-MONTH ANALYSIS RESULTS
    Giorgino, F.
    Guerci, B.
    Garcia-Perez, L. E.
    Boye, K.
    Aigner, U.
    Heitmann, E.
    Federici, Orsini M.
    Zimner-Rapuch, S.
    Rosilio, M.
    Norrbacka, K.
    Sapin, H.
    [J]. VALUE IN HEALTH, 2020, 23 : S506 - S506
  • [5] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Nuesslein, Hubert G.
    Alten, Rieke
    Galeazzi, Mauro
    Lorenz, Hanns-Martin
    Boumpas, Dimitrios
    Nurmohamed, Michael T.
    Bensen, William G.
    Burmester, Gerd R.
    Peter, Hans-Hartmut
    Rainer, Franz
    Pavelka, Karel
    Chartier, Melanie
    Poncet, Coralie
    Rauch, Christiane
    Le Bars, Manuela
    [J]. BMC MUSCULOSKELETAL DISORDERS, 2014, 15
  • [6] Real-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study
    Hubert G Nüßlein
    Rieke Alten
    Mauro Galeazzi
    Hanns-Martin Lorenz
    Dimitrios Boumpas
    Michael T Nurmohamed
    William G Bensen
    Gerd R Burmester
    Hans-Hartmut Peter
    Franz Rainer
    Karel Pavelka
    Melanie Chartier
    Coralie Poncet
    Christiane Rauch
    Manuela Le Bars
    [J]. BMC Musculoskeletal Disorders, 15
  • [7] US real-world effectiveness of secukinumab for the treatment of psoriasis: 6-month analysis from the Corrona Psoriasis Registry
    Strober, Bruce E.
    Germino, Rebecca
    Guana, Adriana
    Greenberg, Jeffrey D.
    Litman, Heather J.
    Guo, Ning
    Lebwohl, Mark
    [J]. JOURNAL OF DERMATOLOGICAL TREATMENT, 2020, 31 (04) : 333 - 341
  • [8] The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
    Eric J. Shiuey
    Nikki A. Mehran
    Melih Ustaoglu
    Qiang Zhang
    Reza Razeghinejad
    Aakriti G. Shukla
    Natasha N. Kolomeyer
    Jonathan S. Myers
    Daniel Lee
    [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2022, 260 : 967 - 974
  • [9] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    [J]. NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2455 - 2463
  • [10] The effectiveness and safety profile of netarsudil 0.02% in glaucoma treatment: real-world 6-month outcomes
    Shiuey, Eric J.
    Mehran, Nikki A.
    Ustaoglu, Melih
    Zhang, Qiang
    Razeghinejad, Reza
    Shukla, Aakriti G.
    Kolomeyer, Natasha N.
    Myers, Jonathan S.
    Lee, Daniel
    [J]. GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 260 (03) : 967 - 974
12345